Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Amgen Stories

2013-09-24 20:22:19

THOUSAND OAKS, Calif. and SHANGHAI, Sept. 24, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ShanghaiTech University today announced the two organizations have entered into a memorandum of understanding (MOU) to form a strategic partnership for the advancement of biopharmaceutical discovery and translational research in China. This agreement includes plans for Amgen to open a China research and development (R&D) center at ShanghaiTech University. "Amgen and ShanghaiTech University...

2013-09-18 20:20:56

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Sept. 18, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Amgen's proposed acquisition of Onyx, was terminated early on Sept. 18, 2013, by the United States Federal Trade Commission. The waiting period was scheduled to expire on Sept. 23, 2013. (Logo:...

2013-09-16 08:28:57

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 16, 2013 /PRNewswire/ -- Today, Investors' Reports announced new research reports highlighting Amgen, Inc. (NASDAQ: AMGN), Gilead Sciences, Inc. (NASDAQ: GILD), Abbott Laboratories (NYSE: ABT), Biogen Idec Inc. (NASDAQ: BIIB), and UnitedHealth Group Inc. (NYSE: UNH). Today's readers may access these reports free of charge - including full price targets, industry analysis and...

2013-09-12 23:18:41

Transparency Market Research published new "Global Osteoporosis Drug Market- China Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2015" market research report to its report store. Browse the report with TOC; visit http://www.transparencymarketresearch.com/osteoporosis-drug-market.html. Albany, New York (PRWEB) September 12, 2013 According to Transparency Market Research “Osteoporosis Drug Market- Global and China market analysis, size, trends and forecast...

2013-09-12 23:00:12

Amgen's new drug AMG services patients struggling with high cholesterol. In reaction to the latest statistics released by Amgen, family lifestyle publication Home And Recreation calls the drug a "New Hope For Combating High Cholesterol". (PRWEB) September 12, 2013 In a recently published article from HomeAndRecreation.org, the family-oriented magazine website alerted readers to the conclusion of Phase 2 testing of experimental cholesterol drug AMG. As reported on Home And...

2013-09-12 08:31:06

THOUSAND OAKS, Calif., Sept. 12, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will present new data from studies of marketed and pipeline products at the 17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress happening Sept. 27 to Oct. 1 in Amsterdam. "Amgen's continued focus on growth through innovation is highlighted by the data that we are presenting at the European Cancer Congress this year," said Sean E. Harper, M.D., executive vice president of Research and...

2013-09-11 16:24:27

Study Links RAS Mutations to Vectibix Clinical Response in Patients With Metastatic Colorectal Cancer THOUSAND OAKS, Calif., Sept. 11, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of a biomarker analysis of Vectibix(®) (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer (mCRC). Published in the New England Journal of Medicine, the analysis found that...

2013-09-10 23:29:28

American physicians have been reversing and stabilizing Alzheimer’s disease since 2005. NWC physicians have been teaching Enbrel injection procedure since 2010 and call upon Maxine Waters to facilitate the widespread implementation of this treatment. (PRWEB) September 10, 2013 The history of medicine is replete with examples of breakthrough treatments languishing, broadly under-utilized for decades. Consider the local anesthetic procaine, which is still in use today. Procaine was...

2013-09-10 16:25:47

THOUSAND OAKS, Calif., Sept. 10, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Friday, Sept. 13, 2013, in London, beginning at 1:00 p.m. Greenwich Mean Time. Arvind Sood, vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also...

2013-09-06 16:22:58

THOUSAND OAKS, Calif., Sept. 6, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 11, 2013, at the Grand Hyatt New York in New York City, beginning at 8:35 a.m. Eastern Daylight Time. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A...